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Background: It remains unclear how executive function (EF) is affected in the stage of amnestic mild cognitive
impairment (aMCI). Previous studies using different methods to assess EF in patients with aMCI have reached
inconsistent conclusions. The aim of the study was to explore the characteristics of EF impairments in patients with
aMCI.
Methods: We investigated three core components of EF (i.e., working memory, response inhibition and task
switching) based on the theoretical model of EF proposed by Miyake et al. (2000) in 34 aMCI patients and 36
healthy elderly controls using computerized tasks programmed with E-prime (the 2-back task and the keep track
task for working memory, the stop-signal task and the Stroop task for response inhibition and the more-odd
shifting task for task switching). The overall EF and the three individual EF components were compared between
groups. For EF components that were impaired, the extent of impairment was compared using a paired analysis.
The aMCI group was further divided into EF-intact and EF-deficit groups according to their performances on the EF
tests in clinical neuropsychological assessments. We tested for group differences among the normal controls and
the EF-intact and EF-deficit aMCI groups and paid special attention to the comparisons between the EF-intact aMCI
group and the control group.
Results: Compared to the control group, overall EF was significantly impaired in patients with aMCI (Wilks’ λ=0.572,
P<0.001). Four tasks (the 2-back task, the keep track task, the stop-signal task and the more-odd shifting task) that
tapped the three core components of EF displayed group differences that favored the normal controls. The results
of the Stroop task revealed no differences in performance between the two groups. The EF-intact aMCI patients
also exhibited significantly impaired capabilities in the four tasks compared to the normal controls. There were no
significant differences in the extent of impairment between the four affected tasks in the aMCI group, suggesting
that the three core EF components were impaired to the same extent.
Conclusions: Both the overall EF and all of the core EF components in the Miyake model of EF (working memory,
response inhibition and task switching) were significantly impaired in aMCI patients, regardless of whether they had
shown obvious clinical executive dysfunction.
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Amnestic mild cognitive impairment (aMCI) is charac-
terized by a decline in memory either alone or in con-
junction with other domains and is a strong harbinger of
eventual progression to Alzheimer's disease (AD) [1].
AD patients often exhibit various degrees of executive
dysfunction [2], but it remains unclear how executive
function (EF) is impaired in aMCI [3-17]. For example,
Traykov et al. [15] demonstrated that task-switching and
response inhibition capabilities, as evaluated by the
Modified Card Sorting Test and Stroop test, were signifi-
cantly decreased in MCI patients. Similarly, Perry et al.
[10] reported specific problems with response inhibition
and attention switching in a group of patients who were
only impaired on episodic memory tests. However, in
Zhang et al.’s study cognitive planning tests (Trail Mak-
ing, Porteus Maze Test and verbal fluency tests) showed
a group difference favoring the normal controls, but
tests for inhibition (Go/NoGo task and Stroop task)
failed to show a significant difference between aMCI and
normal controls [16]. In contrast to all these findings,
Bisiacchi et al. demonstrated preserved EF in aMCI
patients compared to normal elderly people [5].
There are many reasons, such as different criteria for
patient recruitment, that may account for the inconsist-
ent conclusions of previous studies focusing on the EF
of MCI. However, we believe the main reason for the di-
verse results is that until now, there has been no univer-
sally accepted definition of EF and, accordingly, no
widely accepted standardized measure of EF. EF is not a
single-component brain function, and many cognitive
processes, such as response inhibition, resistance to dis-
traction, working memory, planning, problem solving,
set shifting, abstract thinking and judgment, are under
the umbrella of EF [18]. There are numerous neuro-
psychological tests that have been declared to be mea-
sures of EF or constructs thought to be included under
the EF term. However, many of them were not originally
created to measure EF. For example, the Wisconsin card
sort test, a frequently used clinical EF test, was originally
developed to assess abstract learning and concept forma-
tion. Whether and to what extent these tests actually
sample the conceptual domain of the construct of EF
remains uncertain. Moreover, many EF tasks are com-
plex and involve many cognitive processes other than
EF. Thus, it is not surprising that previous studies focus-
ing on different EF components and using different
neuropsychological tests have led to inconsistent
conclusions.
Given the problems mentioned above, choosing a suit-
able EF model is the foundation of a valid clinical study.
There have been a number of EF models based on find-
ings of factor analyses that explored the underlying
dimensions of various batteries of putative EF tests todetermine which combination of EF components is more
representative of EF. Of these, we adopted the Miyake
model (2000) [19] for the current study, in which EF is
divided into three components: inhibition of prepotent
responses (response inhibition), updating and monitor-
ing of working memory representations (working mem-
ory) and shifting between tasks or mental sets (more
frequently referred to as “task switching”). Using latent-
variable analysis, Miyake et al. verified that the three
basic executive functions were moderately correlated
with one another but were distinct. Although there is
controversy regarding the Miyake model, the model has
been validated by studies that used different sets of EF
tasks in various ages of participants [20-22] and has
been widely used in the study of EF [9,23,24]. Another
reason for the choice of the Miyake model is that the
three component EF model is more feasible for use in
clinical studies compared to models containing more
components [25,26]. No previous study has examined
the same three EF components of the Miyake model in
aMCI patients, although there are several studies that
have investigated one or two of these EF components
with or without other EF components in aMCI patients
[3,6,9,15-17,27]. We believe that our study, which is
based on an EF model, is superior to previous studies in
the selection of EF components for evaluation because
in most of the previous studies, the EF components
studied were determined empirically.
In this study, quantitative assessments of the three
core components of EF were achieved using multiple
computerized tasks. Tasks were intentionally selected to
be sensitive and specific for the evaluation of a single
core EF component. No other obvious cognitive pro-
cesses than the target EF component were involved in
the tasks. Computerized versions of the tasks had the
advantage of high sensitivity compared to other versions
of the same task, such as a pen-and-paper version. Based
on the results of previous studies [3-12,15-17], we
hypothesize that aMCI patients have significant deficits
in EF. However, it is difficult to predict whether the
three core components of EF are impaired universally or




The participants included 34 aMCI patients and 36
healthy elderly controls who were recruited through ads
from the memory disorders clinic and the health exam-
ination center of Shengjing Hospital of China Medical
University between June 2010 and October 2011. All
participants received a detailed evaluation, including
medical history, physical and neurological examinations,
psychiatric and cognitive evaluations, laboratory tests,
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Mental State Examination (MMSE) [28], the Chinese
version of the Activity of Daily Living Scale (ADL) [29],
the Clinical Dementia Rating scale (CDR) [30], the Mon-
treal Cognitive Assessment (MoCA) [31] Beijing version,
the Chinese version of Auditory Verbal Learning Test
[32] and the 30-item Geriatric Depression Scale (GDS)
[33] were used in the psychiatric and cognitive evalua-
tions. Laboratory workups included a complete blood
count and differential; serum electrolyte and glucose
measures; liver and renal function tests; thyroid function
tests; HIV and syphilis screening; and serum B12 and
folate levels. All participants had to meet the following
criteria: (1) no history or evidence of psychiatric or neu-
rologic disease, cardiovascular disease, diabetes, thyroid
disease, vitamin B12 deficiency, alcoholism or drug abuse;
(2) an educational level of no less than 6 years; (3) nor-
mal or corrected-to-normal vision and normal color vi-
sion, and (4) no significant changes in conventional MRI
of the brain, such as cerebral infarct, hydrocephalus or
leukoaraiosis. Additionally, aMCI patients all received
CDR scores of 0.5 and met Petersen’s criteria [34] for
amnestic MCI, which are the following: (1) memory com-
plaint by the patient or a reliable informant, (2) object-
ive memory impairment as demonstrated by scores of
more than 1.5 SDs below normative age and education
values and (3) no global cognitive impairment and no
significant impact on daily functions. For the normal con-
trols, further inclusion criteria included a CDR score
of 0 and scores in the normal range on all of the neu-
ropsychological tests. Demographic characteristics andTable 1 Demographic characteristics and neuropsychological
aMCI (n=34) Controls
Age, y 67.9 (6.7) 67.4 (5.0)
Sex(M/Total) 14/34 18/36
Education, y 10.0 (2.9) 11.1 (3.3)
MMSE 28.3 (1.5) 29.5 (0.7)
ADL 20.3 (0.5) 20.1 (0.3)
GDS 6.3 (1.2) 5.4 (1.1)
AVLT 15.1 (2.7) 18.5 (1.9)
Total immediate recall
Long delayed recall 3.4 (0.7) 6.6 (1.4)
MoCA total score 20.5 (3.3) 27.3 (1.7)
Executive items of MoCA:
Alternating Trail Making 0.6 (0.5) 0.9 (0.4)
Clock Drawing Test 2.7 (0.5) 2.8 (0.4)
Abstraction 1.0 (0.6) 1.3 (0.6)
Verbal fluency 0.9 (0.3) 1 (0.2)
NC: normal controls. Mean (standard deviation). MMSE: Mini-Mental State Examinati
ADL: Activity of Daily Living; CDR: Clinical Dementia Rating; MoCA: Montreal Cogniti
Scale.neuropsychological assessments of the patients and con-
trols are presented in Table 1.
As some aMCI patients may already have executive
dysfunction, the EF of aMCI patients who exhibit no ob-
vious clinical executive dysfunction deserves special con-
sideration. We further divided the aMCI patients into 2
groups based on their performances on the 4 EF-related
tests in MoCA (Alternating Trail Making - an analogue
of the Trail Making Test part B (TMT-B), the Clock
Drawing Test (CDT), Abstraction and Verbal fluency)
which had shown good discriminating power for EF in
normal individuals [35]. The two groups were the EF-
intact aMCI group (who received full marks) and the
EF-deficit aMCI group (who did not receive full marks).
Although the clinical evaluation of EF was relatively sim-
ple, the criterion for grouping was strict to identify
aMCI patients who did not have obvious executive defi-
cits. Finally, we included 15 patients in the EF-intact
aMCI group and 19 patients in the EF-deficit aMCI
group.
The study was approved by the Ethics Committee of
the Shengjing Hospital of China Medical University.
Written informed consent was obtained from all
participants.
EF tasks and procedures
The three core EF components were assessed by compu-
terized tasks programmed with E-prime 2.0 (Psychology
Software Tools, Inc., Pittsburg, PA). Response inhibition
was assessed with a Stroop task and a stop-signal task,
working memory was assessed with a 2-back task and aassessments of patients with aMCI and normal controls
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Zheng et al. BMC Neurology 2012, 12:138 Page 4 of 10
http://www.biomedcentral.com/1471-2377/12/138keep track task, and task switching was assessed with a
more-odd shifting task. Responses were logged using the
vocal key or buttons of the E-prime serial response box.
In tasks in which both the vocal key and buttons could
be used as the response modality, the vocal key was
selected to maximally avoid the possible effect of the slo-
wed motor speed of elderly participants on EF measures.
Similarly, only one button of the response box was used,
with simple rules for button pressing in tasks in which
the vocal key could not be used. All stimuli in the ex-
perimental task were presented in size 48 font on a
white background in the middle of a standard 15-in
CRT computer screen. All participants were individually
tested in a quiet room. They sat at a comfortable dis-
tance from the screen (generally approximately 60 cm).
The order of task administration was fixed for all partici-
pants (i.e., stop-signal task, 2-back task, more-odd shift-
ing task, Stroop task and keep track task) with the
constraint that no two tasks that were intended to assess
the same EF component occurred consecutively. All par-
ticipants received one 5-min practice session for each
task before the formal test to become familiar with
requirements of the task. There was a 3-min rest period
between each task. The entire test lasted approximately
1.5 h. To decrease the cognitive burden on participants,
the EF assessment was not performed on the same day
that the psychiatric and cognitive evaluations were per-
formed. Typically, there are control blocks in these
tasks, such as a 0-back block in the 2-back task or a
block of unreadable strings of letters or symbols in the
Stroop task. To shorten the total time consumed by the
assessment, we did not include control blocks in this
study. The lack of control blocks did not affect our
study, as we were only concerned about group differ-
ences in the five performance tasks.
1. Stop-signal task: This study adopted the version of
the stop-signal task used in our previous study [36].
On a Go trial, participants were instructed to press a
button when they saw the Go signal (a circle). The
circle disappeared when the button was pressed or
after 1000 ms had passed without response,
whichever came first. On a Stop trial, a Stop signal (a
cross) appeared shortly after the Go signal. Subjects
were instructed not to press the button on trials with
a Stop signal. A Stop trial also terminated when a
button was pressed or when 1000 ms had elapsed
since the appearance of the Go signal. In every four
trials, there were one Stop trial and three Go trials
that were presented in random order. It was
emphasized to subjects that quick responses to Go
signals and trying to withhold responses to Stop
signals were equally important. A staircase-tracking
algorithm was used to modify the time intervalbetween the Stop and Go signals (stop-signal delay,
SSD) according to the responses of the participants.
The SSD started at 200 ms, and if the subject
succeeded in a Stop trial, the inhibition would be
made more difficult on the subsequent Stop trial by
increasing the SSD by 50 ms. If the subject failed to
inhibit, the next Stop trial was made easier by
decreasing the SSD by 50 ms. By this algorithm,
approximately 50% of all Stop trials could be
inhibited by subjects, which yielded accurate
estimates of stop-signal reaction time (SSRT). SSRT
was the dependent measure in this task. The formal
test consisted of 2 blocks of 100 trials each.
2. 2-back task: In the 2-back paradigm, participants
were required to monitor a series of quickly changing
numbers shown on the center of the screen by
pressing a button whenever a stimulus was presented
that was the same as the one presented two trials
previously. The number disappeared when the
button was pressed or after 1000 ms had passed
without response. Target numbers accounted for 25%
of the stimuli, and the error rate was calculated as
the dependent measure. The 2-back task consisted of
two blocks of 100 trials each.
3. More-odd shifting task: In the more-odd shifting task
(adapted from Salthouse et al. [37]), a series of
numbers (1–4 and 6–9) were displayed on the center
of the screen. Each number appeared for 1000 ms.
There were two conditions in the task: (1) when the
number was colored red, participants were required
to say “big” as quickly as possible if the number
appearing on the screen was more than 5 and “small”
if it was less than 5; and (2) when the number was
colored green, participants were required to say
“odd” or “even” depending on the parity of the
number. In the shifting block (S), which included 48
trials, participants regularly alternated between the
two conditions, switching from one to the other on
every two trials. Thus, the shifting block consisted of
23 switch trials and 25 non-switch trials. The control
block (C) consisted of 24 trials of one condition and
did not require a switch (all trials were non-switch
trials). RTs were measured by vocal key, and a tape
recorder was used to record the answers. Participants
needed to finish two shifting blocks and four control
blocks (two blocks of each condition) in the order of
CCSSCC. The switch cost was the difference
between the average RTs of the switch trials in the
shifting blocks and the average RTs of non-switch
trials in the control blocks.
4. Stroop task: In the Stroop task (adapted from
Belanger et al. [3]), the Chinese characters for green,
red and blue were used to construct items that were
either incongruent, meaning that the name of the
Table 2 Pearson correlation coefficients for the 5








Stop-signal -0.330** 0.372** -
More-odd shifting -0.422** 0.543** 0.480** -
Stroop 0.027 0.247* 0.028 0.238* -
Zheng et al. BMC Neurology 2012, 12:138 Page 5 of 10
http://www.biomedcentral.com/1471-2377/12/138color differed from the ink color (e.g., the word RED
written in blue), or congruent, meaning that the
name of the color was similar to the ink color (e.g.,
the word RED written in red). Items were combined
in random order to create a list in which 75% of the
trials were congruent and 25% of the trials were
incongruent. Participants were instructed to verbally
name the color in which the word was written and
to refrain from reading the printed word. They were
asked to proceed as accurately and as quickly as
possible. Trials terminated when participants
responded or 3000 ms after the appearance of the
word. RTs were measured by vocal key, and a tape
recorder was used to record the answers. The main
dependent measure was the RT difference between
correct responses on incongruent and congruent
trials. The Stroop task consisted of two blocks of 100
trials each.
5. Keep track task: The keep track task was adapted
from Miyake et al. [19]. In each trial of the keep
track task, participants were first shown three target
categories at the bottom of the computer screen. A
list of two-character Chinese words from four
possible categories (i.e., animals, countries, plants
and relatives) was then presented serially and in
random order for 1500 ms each, and the target
categories remained at the bottom of the screen. The
task was to remember the last word presented in
each of the target categories and then to write down
these words at the end of the trial. Three trials
consisting of 8, 12 or 16 words were presented twice
in random order. One point was awarded for each
correctly recalled word, and the total possible score
was 18. The total score was the dependent measure.
Statistical analysis
Statistical analyses were performed using SPSS 11.0. The
alpha level for statistical significance was set at 0.05. T
tests and χ2 tests were used to compare the demo-
graphic and clinical characteristics of the two groups.
We performed a multivariate analysis of variance
(MANOVA) on the five dependent measures to compare
overall executive function between the aMCI patients
and the controls. If the MANOVA demonstrated a sig-
nificant group effect, post-hoc analyses using analysis of
variance (ANOVA) were conducted to examine the
between-group differences on individual EF measures.
The critical α level was adjusted to 0.01 with Bonferroni
correction in the post-hoc comparisons. There was a
possibility that the group EF difference calculated above,
if present, was caused by the decline of EF in aMCI
patients that had already exhibited executive dysfunction
in clinical EF tests. Therefore, all of the EF measures
were compared further using ANOVA with a post-hocBonferroni test among the EF-intact aMCI group, the
EF-deficit aMCI group and the control group. Special at-
tention was paid to the comparison between the EF-
intact aMCI group and the control group. Due to the
small sample size, Cohen’s d was calculated to determine
the effect sizes of the comparisons.
We next performed analyses to explore whether there
were any significant differences in the extent of impair-
ment on the three core executive elements in aMCI
patients. To make the performances on the different
tasks comparable, we transformed the performances on
the different tasks into Z-scores by standardization based
on the entire sample. We were interested in comparing
two components. Using controls, the distribution of the
difference in Z-scores can be determined for the two
components. Both components may have been impaired
in aMCI patients, but if the extent of impairment was the
same for both component (the null hypothesis), the differ-
ences in Z-scores in aMCI patients would be similar to
those in normal controls. Therefore, we performed a t-
test to compare the differences in Z-scores between aMCI
patients and normal controls. The added advantage of
this approach was that the correlation between compo-
nents that existed among some tasks (Table 2) was no
longer an issue when the difference between the scores of
two components was considered.
Finally, a binary logistic regression analysis was per-
formed to assess the relative contributions of perform-
ance on each task to the classification of aMCI/controls.
The healthy control group was used as the reference,
and the aMCI group was used as the outcome. The five
dependent measures of the above EF tasks were used as
predictors.
Results
The demographic and clinical characteristics of aMCI
patients and controls are presented in Table 1. There
were no significant differences in age, sex or degree of
education between the patients and the controls. With
regard to the clinical neuropsychological assessments, t-
tests showed that the two groups significantly differed
on measures of MMSE, GDS, AVLT (including total im-
mediate recall and long delayed recall) and MoCA,
Table 3 Comparison of performances on the five EF tasks between aMCI and normal controls
aMCI (n=34) NC (n=36) F P Cohen’s d
Keep track 8.9 (2.6) 12.1 (2.6) 25.947 <0.001 -1.230
2-back 0.59 (0.2) 0.37 (0.2) 19.587 <0.001 1.099
Stop-signal 300.5 (31.7) 270.1 (35.0) 14.513 <0.001 0.910
More-odd shifting 353.6 (92.1) 237.9 (86.1) 29.502 <0.001 1.297
Stroop 330.7 (142.0) 319.2 (69.5) 0.188 0.666 0.103
NC: normal controls. Mean (standard deviation).
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did not differ between the two groups (P = 0.074, Cohen’s
d = 0.485). With regard to the 4 EF items of MoCA, the
results of the Alternating Trail Making test revealed sig-
nificant group differences (P = 0.039, Cohen’s d = 0.663),
but the other three tests did not (Clock Drawing Test:
P = 0.164,Cohen’s d = 0.221, Abstraction: P = 0.060, Cohen’s
d = 0.5,Verbal fluency: P = 0.157, Cohen’s d = 0.392).
The overall MANOVA on all task measures was sig-
nificant (Wilks’ λ = 0.572,F = 9.572, P<0.001). Follow-up
ANOVA revealed significant group differences on all
tasks except the Stroop task. Compared to the controls,
the aMCI patients exhibited poorer performance on the
keep track task (F = 25.947, P< 0.001, Cohen’s d = 1.230),
the 2-back task (F = 19.587, P< 0.001, Cohen’s d = 1.099),
the stop-signal task (F= 14.513, P< 0.001, Cohen’s d= 0.910)
and the more-odd shifting task (F = 29.502, P< 0.001,
Cohen’s d = 1.297)(Table 3).
The ANOVA with post-hoc Bonferroni test performed
among the NC, the EF-intact aMCI group and the EF-
deficit group revealed that both the EF-intact aMCI
group and the EF-deficit aMCI group differed signifi-
cantly from the control group on all measures of EF
tasks except for the Stroop task (Table 4). In the more-
odd shifting task, the EF-deficit group displayed greater
impairment than the EF-intact aMCI group. In the keep
track task, the 2-back task and the stop-signal task, there






Age, y 67.4 (5.0) 68.9 (6.5) 66.5 (7.0) 0.550
Sex(M/Total) 18/36 7/15 7/19 0.875
Education, y 11.1 (3.3) 10.3 (2.8) 9.67 (3.0) 1.242
Keep track 12.1 (2.6) 9.2 (2.5) 8.6 (2.6) 13.056
2-back 0.37 (0.2) 0.58 (0.24) 0.61 (0.22) 9.790
Stop-signal 270.1 (35.0) 291.9 (15.4) 307.4 (39.3) 8.256
More-odd shifting 237.9 (86.1) 310.5 (29.3) 387.7 (110.0) 19.415
Stroop 319.2 (69.5) 332.6 (133.6) 329.2 (151.9) 0.096
NC: normal controls. Mean (standard deviation). Comparison was performed using A
EF-deficit aMCI group and the normal control group.In aMCI patients, the paired analysis using Z scores
did not identify significant differences in the extent of
impairments between the four affected tasks, suggesting
that the three core components of EF were impaired to
the same extent (Table 5). The binary logistic regression
analysis with the five performance measures entered as
covariates demonstrated that the measures of the keep
track task and the more-odd shifting task had predictive
value for the identification of aMCI (OR = 1.665, with a
95% confidence interval from 1.112 to 2.494, P = 0.013
and OR = 0.981, with a 95% confidence interval from
0.967 to 0.995, P = 0.01, respectively; Table 6).
Discussion
Although Bisiacchi et al. showed that the EF of MCI
patients was intact [5], additional studies demonstrated
EF deficits in patients with MCI [3,4,6-9,15]. Our study
showed that overall EF of aMCI patients was signifi-
cantly impaired. More importantly, this study, based on
the Miyake EF model, revealed that all the three core
components of EF (i.e., working memory, task switching
and response inhibition) were significantly impaired in
aMCI patients and that the degree of impairment in the
three core components did not differ significantly.
Patients who did not show executive dysfunction in clin-
ical assessments also exhibited significantly impaired EF
in computerized EF tasks that assessed the three core EF
components when compared to normal controls. Recentt aMCI, EF-deficit aMCI and normal controls










<0.001 0.002 1.137 <0.001 1.346 1.000 0.235
<0.001 0.008 0.951 0.001 1.142 1.000 0.130
0.001 0.009 0.806 0.004 1.002 0.276 0.519
<0.001 0.022 1.098 <0.001 1.496 0.034 0.959
0.908
NOVA with a post-hoc Bonferroni test among the EF-intact aMCI group, the
Table 5 Paired analysis of the differences in the
performance Z-scores among the four affected tasks
between the aMCI and the control groups
t P
Z(Keep track)- Z(2-back) 0.431 0.668
Z(Keep track)- Z(More-odd shifting) -0.188 0.851
Z(Keep track)- Z(Stop-signal) 0.759 0.450
Z(2-back)- Z(More-odd shifting) -0.668 0.506
Z(2-back)- Z(Stop-signal) -0.394 0.695
Z(Stop-signal)- Z(More-odd shifting) -1.066 0.290
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contributor to impairment on everyday functioning in
MCI patients, even when accounting for the degree of
memory deficit [11,17]. Thus, clinicians should be fully
aware of the importance of making a thorough assess-
ment of EF in aMCI patients.
The findings of this study were inconsistent with pre-
vious studies that revealed selectively impaired EF com-
ponents in MCI [6,16]. As mentioned in the beginning,
the inconsistency was partially caused by the evaluation
of different EF components in different studies. Here,
conclusions reached by the selection of different EF
components were not within the scope of this discus-
sion, and we focused only on studies that involved any
of the three core EF components in the Miyake model.
Although the previous studies differed greatly in the
methods that were used to evaluate the two executive
components, in regards to working memory and task-
switching, the studies consistently showed that working
memory [6,8,9,12,17,38] and task-switching [4,9,15,39-42]
were impaired in MCI patients. Moreover, Aretouli et al.
highlighted the role of working memory in everyday
functioning in MCI patients [17]. In their study, the con-
tribution of the three components of EF (i.e., planning/
problem-solving, working memory, and judgment) to
everyday functioning in patients with MCI was investi-
gated. Only working memory contributed significantly to
functional status after controlling for demographic, health-
related and other cognitive factors. Ewers et al. reportedTable 6 Summary of the Logistic regression analysis:
contribution of performance in each task for the
classification of aMCI/controls
Wald OR 95%CI for OR P
Keep-track 6.122 1.665 1.112-2.494 0.013
2-back 0.035 0.680 0.012-37.958 0.851
Stop-signal 1.288 0.986 0.961-1.011 0.256
More-odd shifting 6.705 0.981 0.967-0.995 0.010
Stroop 1.155 1.001 0.995-1.008 0.701
OR: odds ratio. CI: confidence intervals. The control group was used as
reference.that the Trail Making B test, a commonly used method
to assess task switching, was one of the best predictors
of conversion from MCI to Alzheimer's disease dementia
[42]. Our study, using multiple computerized psycho-
logical tasks, revealed a decline in working memory and
task switching in aMCI patients, including those whose
EF appeared intact in clinical assessments. Meanwhile,
the logistic regression analyses revealed that the perfor-
mances on the keep-track task and the more-odd shifting
task, which assess working memory and task switching,
respectively, were potential predictors of aMCI. This
conclusion will require further investigation in a large
sample of patients. All of these studies, including ours,
provide strong evidence of impairments in working mem-
ory and task switching in aMCI patients.
Controversy remains regarding the impairment of re-
sponse inhibition in aMCI patients. Using different
methods to evaluate response inhibition, some studies
showed that the response inhibition of aMCI patients
declined significantly compared to normal elderly con-
trols [3,9,10,15], while other studies did not report a dif-
ference [16,27]. The results of studies that used the same
task, such as the Stroop task, were inconsistent
[3,15,16,27]. In our study, the results of the two tasks
that evaluated response inhibition were not consistent.
Performance on the Stroop task in aMCI patients was
not affected, but performance on the stop-signal task
was worse than in controls. In our study, the final con-
clusion on response inhibition of aMCI patients was
based on the results of the stop-signal task, which
detected a mild change in response inhibition. We be-
lieve that, in addition to the use of different criteria in
patient recruitment, the main reason for the controver-
sial results regarding response inhibition of MCI patients
in previous studies and in this study is the methodo-
logical differences across these studies, such as the use
of different tasks or different designs of the same task,
which may differ greatly in their detection capacities.
For example, in similar groups of MCI patients, Belle-
ville et al. did not find any abnormalities in inhibition
when they used the Hayling procedure and a clinical
pen-and-paper Stroop task [27], while partially impaired
inhibition was observed when they used a computerized
Stroop task [3]. Therefore, sometimes negative results
can be caused by the use of tasks with insufficient sensi-
tivity. Selection of the most proper task or the use of
multiple tasks is feasible in both clinical and research
settings.
The results of our Stroop task, which was a computer-
ized version, did not reveal the group differences that
were shown by the results of the stop-signal task. The
relatively simple design of our Stroop task may partially
account for the insufficient sensitivity of the task. An-
other possible explanation is that the Stroop task itself
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than the stop-signal task. Response inhibition is the
most extreme and straightforward form of inhibitory
control and is generally required in all types of cognitive
control. Our study is the first to use a stop-signal task to
assess response inhibition in aMCI patients. We believe
that the experimental design of the stop-signal task in
our study is much better at measuring response inhib-
ition than other inhibitory tasks, such as the Stroop task.
The Stroop task is a measure of selective attention and
attention control and is therefore more related to cogni-
tive inhibition than response inhibition [43]. In a study
of 112 MCI patients, Heflin et al. found that perform-
ance on the Stroop task was not correlated to disinhib-
ition, indicating that performance on the Stroop task
was a poor measurement of behavioral disinhibition
[44]. In contrast, the stop-signal task rarely involves cog-
nitive processes other than response inhibition. Mean-
while, we used a staircase-tracking algorithm in the
design of our stop-signal task to ensure that approxi-
mately 50% of all stop trials could be inhibited by the
subjects, which yielded accurate estimates of SSRT. This
kind of quantitative evaluation of response inhibition
cannot be achieved in other tasks. We speculate that it
is due to these reasons that the stop-signal task detected
a change in response inhibition in the aMCI patients in
our study while the Stroop task did not. Decline in re-
sponse inhibition can affect the capability of a patient to
respond in a timely and appropriate manner to sudden
changes in the external environment, such as is needed
when driving.
It should be emphasized that this study was only con-
cerned with response inhibition of aMCI patients and
that other inhibitory systems, such as inhibition of
thoughts and language, were not included. We cannot
conclude that other inhibitory systems are similarly
impaired in aMCI patients. Amieva et al. proposed that
not all inhibitory mechanisms are uniformly impaired in
Alzheimer’s disease. They concluded that automatic in-
hibition (e.g., inhibition of return) was barely affected
but that controlled inhibition (e.g., stop-signal task) was
greatly affected [45]. The effects of MCI and AD on dif-
ferent inhibitory systems need to be investigated further.
It is well known that aMCI can be classified into single
domain and multiple domain subtypes depending on the
profile of cognitive deficits. The so-called “single-do-
main” aMCI patients should have intact EF. However, as
shown in some recent studies [13,14], clinically diag-
nosed single-domain aMCI patients exhibited significant
EF deficits when they performed some special EF tasks
that were not included in the routine clinical neuro-
psychological assessment. As this study only concerned
with EF of aMCI patients and the sample size was small,
we did not classify the aMCI patients into single-domainand multiple-domain subtype groups. Instead, we
divided our aMCI patients into subgroups based on their
performances on clinical EF tests. Compared to normal
controls, not only the EF-deficit aMCI patients but also
the EF-intact aMCI patients exhibited significant impair-
ments on all the three core EF components when the
more sensitive computerized tasks were used for evalu-
ation of EF. The EF-deficit aMCI patients showed
greater decreases in task switching capabilities compared
to the EF-intact patients. It is highly likely that all aMCI
patients have EF impairments that may differ in severity
compared to normal elderly people.
It is understandable that the overall EF begins to de-
cline in aMCI. Although atrophy of the medial temporal
lobe structures is the most outstanding feature of brain
atrophy in aMCI patients, recent studies on brain
morphometry have shown that atrophy also exists in
other brain regions, such as in the lateral and anterior
parts of the temporal cortex, the posterior cingulate cor-
tex and the frontal cortex [4,46]. There is widespread
agreement that the frontal lobe, especially the prefrontal
cortex (PFC), is responsible for EF. Many fMRI studies
have provided strong evidence that the PFC serves as
the most important neural substrate for the three core
components of EF in Miyake’s model [36,47,48]. Both
the atrophy of the dorsolateral PFC [49] and the impair-
ment of white matter in the frontal lobe [50] have been
shown to be related to the decline of EF in aMCI and
AD patients. Therefore, pathological changes in the
frontal lobe may be the basis of the decrease in all core
EF components in aMCI patients.
There are some limitations to this study. First, our
sample is relatively small. Second, there is a lack of
follow-up data. aMCI is a heterogeneous clinical entity
and not all aMCI patients will develop Alzheimer’s dis-
ease. Data from aMCI patients who progress into AD
are more valuable. Follow-up work is ongoing. Third,
the clinical assessment of EF is relatively simple in this
study. More detailed clinical assessments of EF were not
included as the present neuropsychological assessments
and the five EF tasks took a long time. Thus the criteria
for the selection of “EF-intact” patients are not very
strict in this study. Last, the possible effect of difficulties
in other cognitive functions (for instance, attention) on
EF impairment was not considered in this study, but we
believe it needs further thorough investigation.
Conclusion
In conclusion, the current study showed that both the
overall EF and all of the core EF components in the
Miyake model of EF were significantly impaired in aMCI
patients. There was no significant difference among the
degrees of impairment of different core EF components.
The aMCI patients who did not show obvious clinical
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way, which suggested that the impairment of EF was
common in aMCI patients.
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